Over 44,000 Tuberculosis Cases Detected in Jakarta, Raising Infection Spread Concerns
Over 44,000 tuberculosis (TB) cases have been detected in Jakarta. With a treatment completion rate of only 76%, concerns are rising about the risk of further infection spread. Health authorities plan to accelerate case finding and contact tracing efforts.
Read up to 3 eligible full articles per Japan day (JST) for free
Create a free account to open up to 3 eligible full articles per Japan calendar day (JST). Headlines and summaries remain available across ASEAN 7.
Related articles
- Student Demonstrations on Youth Pledge Day, Traffic Re-routing in 4 Jakarta Locations
On Indonesia's Youth Pledge Day, October 28, large student demonstrations are planned across Jakarta. Police anticipate traffic congestion and will implement traffic control measures on major roads. Demonstrators are presenting a range of demands, including environmental issues, education costs, and anti-corruption efforts.
- Six Indonesian Pesantren Receive Mandaya Awards, Ministry Encourages National Model Status
Six Islamic boarding schools (Pesantren) in Indonesia have received the 2026 Mandaya Awards. The Ministry of Religious Affairs announced its intention to promote these Pesantren as national role models.
- Indonesia's 'Sekolah Rakyat': Challenges and Progress in Educational Support for Vulnerable Children
One year after its launch, the Indonesian government continues to improve services for 'Sekolah Rakyat' (People's School), aimed at children from poor and vulnerable families. Facing challenges such as students' psychological needs and a shortage of educators and dorm supervisors, the program strives to provide tailored support and educational opportunities.
- Prabowo Urges Accelerated Malaria Vaccine Research; BRIN Confident in 3-Year Production
Indonesian Defense Minister Prabowo Subianto has ordered accelerated research and development for a domestic malaria vaccine. In response, the National Research and Innovation Agency (BRIN) expressed confidence in commencing production within three years, signaling a move towards public health improvement and pharmaceutical self-sufficiency.